ChromaDex Corporation

NasdaqCM:CDXC Stock Report

Market Cap: US$184.7m

ChromaDex Management

Management criteria checks 3/4

ChromaDex's CEO is Rob Fried, appointed in Jun 2018, has a tenure of 8.92 years. total yearly compensation is $1.16M, comprised of 43.1% salary and 56.9% bonuses, including company stock and options. directly owns 2.09% of the company’s shares, worth $3.86M. The average tenure of the management team and the board of directors is 5 years and 7.1 years respectively.

Key information

Rob Fried

Chief executive officer

US$1.2m

Total compensation

CEO salary percentage43.1%
CEO tenure6yrs
CEO ownership2.1%
Management average tenure5yrs
Board average tenure7.1yrs

Recent management updates

Shareholders Will Likely Find ChromaDex Corporation's (NASDAQ:CDXC) CEO Compensation Acceptable

Jun 15
Shareholders Will Likely Find ChromaDex Corporation's (NASDAQ:CDXC) CEO Compensation Acceptable

Recent updates

Shareholders Will Likely Find ChromaDex Corporation's (NASDAQ:CDXC) CEO Compensation Acceptable

Jun 15
Shareholders Will Likely Find ChromaDex Corporation's (NASDAQ:CDXC) CEO Compensation Acceptable

Positive Sentiment Still Eludes ChromaDex Corporation (NASDAQ:CDXC) Following 26% Share Price Slump

Jun 05
Positive Sentiment Still Eludes ChromaDex Corporation (NASDAQ:CDXC) Following 26% Share Price Slump

Should You Think About Buying ChromaDex Corporation (NASDAQ:CDXC) Now?

Apr 05
Should You Think About Buying ChromaDex Corporation (NASDAQ:CDXC) Now?

Not Many Are Piling Into ChromaDex Corporation (NASDAQ:CDXC) Just Yet

Feb 28
Not Many Are Piling Into ChromaDex Corporation (NASDAQ:CDXC) Just Yet

ChromaDex Corporation's (NASDAQ:CDXC) Intrinsic Value Is Potentially 85% Above Its Share Price

Jan 29
ChromaDex Corporation's (NASDAQ:CDXC) Intrinsic Value Is Potentially 85% Above Its Share Price

Market Cool On ChromaDex Corporation's (NASDAQ:CDXC) Revenues

Jun 08
Market Cool On ChromaDex Corporation's (NASDAQ:CDXC) Revenues

We're Hopeful That ChromaDex (NASDAQ:CDXC) Will Use Its Cash Wisely

Mar 31
We're Hopeful That ChromaDex (NASDAQ:CDXC) Will Use Its Cash Wisely

ChromaDex inks new commercial supply agreement for its Niagen ingredient with Nestlé

Oct 11

ChromaDex forms JV in Asia for Tru Niagen; plans to raise $3.1M via stock sale

Oct 03

ChromaDex in pact to introduce anti-aging compound in Brazil

Sep 01

Ayana Bio appoints Frank Jaksch as CEO

Aug 24

ChromaDex wins patent challenge as US regulator rejects Thorne Research's demand to invalidate patent

Aug 15

Some ChromaDex Corporation (NASDAQ:CDXC) Analysts Just Made A Major Cut To Next Year's Estimates

Mar 15
Some ChromaDex Corporation (NASDAQ:CDXC) Analysts Just Made A Major Cut To Next Year's Estimates

We're Not Very Worried About ChromaDex's (NASDAQ:CDXC) Cash Burn Rate

Mar 03
We're Not Very Worried About ChromaDex's (NASDAQ:CDXC) Cash Burn Rate

Companies Like ChromaDex (NASDAQ:CDXC) Can Afford To Invest In Growth

Nov 19
Companies Like ChromaDex (NASDAQ:CDXC) Can Afford To Invest In Growth

CEO Compensation Analysis

How has Rob Fried's remuneration changed compared to ChromaDex's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

-US$4m

Dec 31 2023US$1mUS$500k

-US$5m

Sep 30 2023n/an/a

-US$6m

Jun 30 2023n/an/a

-US$6m

Mar 31 2023n/an/a

-US$11m

Dec 31 2022US$1mUS$500k

-US$17m

Sep 30 2022n/an/a

-US$20m

Jun 30 2022n/an/a

-US$28m

Mar 31 2022n/an/a

-US$27m

Dec 31 2021US$1mUS$500k

-US$27m

Sep 30 2021n/an/a

-US$28m

Jun 30 2021n/an/a

-US$23m

Mar 31 2021n/an/a

-US$21m

Dec 31 2020US$1mUS$519k

-US$20m

Sep 30 2020n/an/a

-US$23m

Jun 30 2020n/an/a

-US$26m

Mar 31 2020n/an/a

-US$30m

Dec 31 2019US$2mUS$487k

-US$32m

Sep 30 2019n/an/a

-US$32m

Jun 30 2019n/an/a

-US$33m

Mar 31 2019n/an/a

-US$33m

Dec 31 2018US$5mUS$379k

-US$33m

Sep 30 2018n/an/a

-US$34m

Jun 30 2018n/an/a

-US$29m

Mar 31 2018n/an/a

-US$23m

Dec 30 2017US$4mUS$231k

-US$17m

Compensation vs Market: Rob's total compensation ($USD1.16M) is about average for companies of similar size in the US market ($USD1.62M).

Compensation vs Earnings: Rob's compensation has increased whilst the company is unprofitable.


CEO

Rob Fried (64 yo)

6yrs

Tenure

US$1,160,206

Compensation

Mr. Robert N. Fried, also known as Rob, has been the Chief Executive Officer of ChromaDex Corp. since June 22, 2018 and its a Director since July 2015. Mr. Fried was the Chief Operating Officer of ChromaDe...


Leadership Team

NamePositionTenureCompensationOwnership
Frank Jaksch
Co-Founder & Chairman24.3yrsUS$92.31k3.05%
$ 5.6m
Robert Fried
CEO & Director6yrsUS$1.16m2.09%
$ 3.9m
Brianna Gerber
Chief Financial Officer1.8yrsUS$691.59k0.038%
$ 70.0k
Andrew Shao
Senior Vice President of Global Regulatory & Scientific Affairs4.3yrsno datano data
Alex Worsham
Vice President of Global Marketing & Communicationsno datano datano data
David Kroes
Senior Vice President of People Mattersno datano datano data
Chu Yan
Managing Director of Asia Pacific5.7yrsno datano data
Jason Campbell
Senior Vice President of Business Developmentless than a yearno datano data
Kendall Knysch
Head of Media Relations & Partnershipsno datano datano data

5.0yrs

Average Tenure

56yo

Average Age

Experienced Management: CDXC's management team is seasoned and experienced (5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Frank Jaksch
Co-Founder & Chairman24.3yrsUS$92.31k3.05%
$ 5.6m
Robert Fried
CEO & Director8.9yrsUS$1.16m2.09%
$ 3.9m
Rudolph Tanzi
Member of Scientific Advisory Board7yrsno datano data
Steven Rubin
Lead Independent Director7.3yrsUS$117.31k0.0092%
$ 17.1k
Roger Kornberg
Chairman of the Scientific Advisory Board9.9yrsno datano data
J. German
Member of Scientific Advisory Board9.8yrsno datano data
Ann Cohen
Independent Director2.2yrsUS$89.81k0%
$ 0
Wing Yu
Non-Executive Director6.8yrsUS$67.31k0%
$ 0
Kristin Patrick
Independent Director2.2yrsUS$82.31k0%
$ 0
Charles Brenner
Chief Scientific Advisor & Member of Scientific Advisory Board9.8yrsno datano data
John Walker
Member of Scientific Advisory Board6.1yrsno datano data
Brunie Felding
Member of the Scientific Advisory Board4.9yrsno datano data

7.1yrs

Average Tenure

63.5yo

Average Age

Experienced Board: CDXC's board of directors are considered experienced (7.1 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.